ARCHIVES

Ovarian Suppression Treatment Plus Tamoxifen Can Lower Recurrence Risk

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Researchers Identify Mutation Linked to Inherited Risk of ALL

September 27, 2013

In Brief: Money Buys Progress In Cancer Research, DeVita says; John Montgomery To Give Clowes Lecture

April 29, 1983

Four Detroit Institutions Merge Cancer Clinical, Research Programs

July 15, 1994

FDA Advisors Discuses Establishment of Standards for Showing Equivalence

December 17, 1999

ASTRO Issues Statement On APBI For Breast Cancer

August 28, 2009

Lombardi Center Officials Say New Partnership To Provide For Expansion In Services, Patients.

February 23, 2001